Lupin Gets USFDA Approval for Generic Pitolisant Tablets in the US
Lupin announced the approval on August 17, 2026, stating that its Abbreviated New Drug Application had received final clearance from the USFDA. The tablets are bioequivalent to Wakix, the reference medicine associated with Harmony Biosciences.